Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

Abstract

The results of this study suggest that celecoxib may be an effective adjuvant agent in the management of patients with major depression and anti-inflammatory therapies should be further investigated.